全文获取类型
收费全文 | 72篇 |
免费 | 8篇 |
专业分类
儿科学 | 11篇 |
基础医学 | 10篇 |
口腔科学 | 6篇 |
临床医学 | 8篇 |
内科学 | 9篇 |
神经病学 | 2篇 |
特种医学 | 8篇 |
外科学 | 5篇 |
综合类 | 1篇 |
预防医学 | 4篇 |
药学 | 2篇 |
肿瘤学 | 14篇 |
出版年
2022年 | 1篇 |
2020年 | 1篇 |
2019年 | 1篇 |
2018年 | 3篇 |
2017年 | 1篇 |
2016年 | 3篇 |
2015年 | 1篇 |
2013年 | 3篇 |
2012年 | 4篇 |
2011年 | 6篇 |
2010年 | 3篇 |
2009年 | 3篇 |
2008年 | 3篇 |
2007年 | 6篇 |
2006年 | 2篇 |
2005年 | 2篇 |
2004年 | 3篇 |
2003年 | 1篇 |
2001年 | 1篇 |
2000年 | 1篇 |
1999年 | 2篇 |
1998年 | 2篇 |
1997年 | 4篇 |
1996年 | 1篇 |
1994年 | 1篇 |
1993年 | 1篇 |
1991年 | 4篇 |
1989年 | 3篇 |
1988年 | 3篇 |
1987年 | 2篇 |
1986年 | 2篇 |
1984年 | 1篇 |
1981年 | 4篇 |
1978年 | 1篇 |
排序方式: 共有80条查询结果,搜索用时 343 毫秒
1.
2.
We describe the case of a 40‐year‐old woman who presented with a pararenal hyaline‐vascular type Castleman’s disease that had an arterial supply from the renal artery and a draining vein as showed by multidetector CT. Identification of the renal artery relationship to the feeding vessel of the mass is critical to prevent potential surgical complications. 相似文献
3.
目的探讨总结肝癌自发性破裂出血的诊治经验。方法回顾性分析海口市人民医院自1992年1月~2004年5月收治26例原发性肝癌破裂出血的临床资料。结果该组原发性肝癌自发性破裂出血病例中,行肝癌切除术者,生存时间长。结论原发性肝癌破裂出血行肝叶切除和肝局部切除不但可以彻底有效地止血,而且可以达到切除肿瘤的目的,是首选的方法,是一种安全、可行的方法.如果病人情况不允许,可先行保守治疗或介入治疗(TAE),争取行Ⅱ期或延期肝切除术。而肝动脉结扎加胃网膜右静脉插管化疗,注入无水酒精等癌灶综合治疗为一种有效的辅助措施。 相似文献
4.
Bridging bronchus: a rare airway anomaly 总被引:1,自引:0,他引:1
5.
6.
N Gad-el-Mawla M R Hamza S Abdel-Hadi O el-Tannir M H Hussein A el-Haddad M Adde I Magrath 《Hematological oncology》1991,9(4-5):281-286
Pediatric non-Hodgkin's lymphoma (NHL) constitutes 16 per cent of pediatric malignancies reported to the National Cancer Institute (NCI) in Cairo. The adopted treatment for these cases was, from 1982 to July 1985, a modified St Jude's regimen consisting of: vincristine, cyclophosphamide, adriamycin, prednisone and intrathecal methotrexate for the first 6 weeks for induction, followed by cranial irradiation for cranial prophylaxis. Patients in remission received maintenance therapy for 18 months. Of 32 patients complete remission (CR) was achieved in 24 patients (75 per cent); partial remission (PR) in one patient (3 per cent); five patients showed no response (15 per cent) while two patients died during the induction phase. At 60+ months follow-up, 60 per cent of cases are still alive, disease-free, and overall survival is 66 per cent. A new protocol was adopted in 1985, consisting of alternating cycles: A and B, for 4-8 cycles. Cycle A: cyclophosphamide, high dose ara-C, adriamycin, and vincristine. Cycle B: ifosfamide, methotrexate, VP 16, with intrathecal methotrexate. The response in 39 cases is: CR in 31 cases (82 per cent); PR in four cases (10 per cent); no response in three cases (8 per cent). At 60+ months, the disease-free survival is 60 per cent, and overall survival 80 per cent. This new protocol has the advantage of: short duration of therapy and so better patient compliance, no maintenance therapy or cranial irradiation with its sequelae in the future. Moreover, it has a better overall survival. 相似文献
7.
We report the results of two phase II trials of ifosfamide in very high risk patients with either partially responsive or recurrent non-Hodgkin's lymphomas. In the first study, in which patients were extremely heavily pretreated (50 per cent had received a very intensive salvage regimen containing very high dose cyclophosphamide), there were two complete responses, two partial responses and one objective (minimal) response among 14 patients treated. Toxicity was acceptable even in this end-stage patient group. We concluded that ifosfamide is an active agent even in patients with tumours resistant to cyclophosphamide. The second trial was a pilot study in 13 patients of a regimen incorporating VP16, ifosfamide/mesna, and high dose ara-C (VIPA). There were four complete responses, five partial responses and two objective responses. Two patients died in complete remission from toxic complications, while a third, with a stably regressed mediastinal mass died after completion of the protocol. While very toxic, we considered that this regimen was highly effective, and have since incorporated a slightly less intensive combination of the same drugs into the primary therapy of high risk patients. Since the primary toxicity of the VIPA combination was myelosuppression, the use of a modified protocol incorporating colony stimulating factors to ameliorate the side-effects and possibly increase dose rate is worthy of further exploration in patients with recurrent B cell tumours. 相似文献
8.
9.
Background
Biological control methods are once again being given much research focus for malaria vector control. This is largely due to the emerging threat of strong resistance to pesticides. Larvivorous fish have been used for over 100 years in mosquito control and many species have proved effective. In the western Kenyan highlands the larvivorous fish Oreochromis niloticus L. (Perciformes: Cichlidae) (formerly Tilapia nilotica) is commonly farmed and eaten but has not been previously tested in the field for malaria mosquito control. 相似文献10.
Nicolas Roux M.D. Fabien Doguet M.D. Pierre-Yves Litzler M.D. Alfred Tabley M.D. Jean-Michel Adde Jean-François Fournier M.D. Michel Redonnet M.D. Catherine Nafeh Bizet M.D. François Bouchart M.D. Catherine Haas Hubscher M.D. † Jean-Paul Bessou M.D. 《Journal of cardiac surgery》2008,23(2):163-164
Abstract The patient, who had undergone a complete cure of a tetralogy of Fallot 25 years previously, was discovered to have an ascending aorta aneurysm on echography. Bentall's procedure was carried-out, using a modified indirect coronary artery transplantation based on the Cabrol technique. As reported in the literature complications are mainly right sided and less frequently occur on the left side in this disease. Including the hypothesis of the overload volume which may provoke aortic root dilation, there is also an intrinsic pathology of the media which could often be related to embryogenesis abnormalities, i.e., abnormal migration of cardiac neural crest cells which may explain this condition. 相似文献